Literature DB >> 15066692

Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994.

Ryne Paulose-Ram1, Bruce S Jonas, Denise Orwig, Marc A Safran.   

Abstract

OBJECTIVE: We estimated prescription psychotropic medication use among US adults.
METHODS: We examined household interview data from the third National Health and Nutrition Examination Survey (1988-1994) for persons 17 years and older (n=20,050). STUDY DESIGN AND
SETTING: An estimated 10 million adults (5.5%) reported psychotropic medication use during a 1-month period. The use of anxiolytics, sedatives, and hypnotics (ASH) was most common (3.2%), followed by antidepressants (2.3%), antipsychotics (0.7%), and antimanics (0.1%). Psychotropic medication use was more prevalent among women than men (P<.001), non-Hispanic whites than non-Hispanic blacks (P<.001) and Mexican Americans (P<.001), and older rather than younger age groups (P<.001). Psychotropic medication use was also most common among those below the federal poverty level, those with no high school education, and among insured persons. Only 1% of adults used two or more psychotropic medications monthly.
CONCLUSION: Many adults use psychotropic medications on a monthly basis. ASH users comprised the largest proportion of psychotropic medication users. Patterns of use varied by several socio-demographic factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066692     DOI: 10.1016/j.jclinepi.2003.05.001

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  25 in total

1.  Psychotropic medication claims among religious clergy.

Authors:  Steven M Frenk; Sarah A Mustillo; Steven L Foy; Whitney D Arroyave; Elizabeth G Hooten; Kari H Lauderback; Keith G Meador
Journal:  Psychiatr Q       Date:  2013-03

2.  Racial/ethnic differences in the association between obesity and major depressive disorder: findings from the Comprehensive Psychiatric Epidemiology Surveys.

Authors:  Amelia R Gavin; Tessa Rue; David Takeuchi
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

3.  Psychotropic medications and the risk of fracture: a meta-analysis.

Authors:  Bahi Takkouche; Agustín Montes-Martínez; Sudeep S Gill; Mahyar Etminan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil.

Authors:  Sergio L Blay; Gerda G Fillenbaum; José C Pitta; Erica T Peluso
Journal:  Int Clin Psychopharmacol       Date:  2014-05       Impact factor: 1.659

5.  Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan.

Authors:  I-Chia Chien; Shin-Huey Bih; Ching-Heng Lin; Yiing-Jenq Chou; Wen-Guang Lee; Cheng-Hua Lee; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-20       Impact factor: 4.328

6.  Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample.

Authors:  Jasper A J Smits; David Rosenfield; Amber A Mather; Candyce D Tart; Christine Henriksen; Jitender Sareen
Journal:  J Psychiatr Res       Date:  2010-11       Impact factor: 4.791

7.  National use of prescription medications for insomnia: NHANES 1999-2010.

Authors:  Suzanne M Bertisch; Shoshana J Herzig; John W Winkelman; Catherine Buettner
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

8.  Trends, correlates, and disease patterns of antidepressant use among elderly persons in Taiwan.

Authors:  Chia-Lun Kuo; I-Chia Chien; Ching-Heng Lin; Shu-Wen Cheng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-03-31       Impact factor: 4.328

9.  Socio-economic and behavioral determinants of prescription and non-prescription medicine use: the case of Turkey.

Authors:  Selcen Öztürk; Dilek Başar; İlhan Can Özen; Arbay Özden Çiftçi
Journal:  Daru       Date:  2019-11-16       Impact factor: 3.117

10.  Psychotropic Drug Use in São Paulo, Brazil--An Epidemiological Survey.

Authors:  Maria Ines Quintana; Sergio Baxter Andreoli; Marcela Poctich Peluffo; Wagner Silva Ribeiro; Marcelo M Feijo; Rodrigo Affonseca Bressan; Evandro S F Coutinho; Jair de Jesus Mari
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.